Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Admira Fusion 5

K-Number: K230877 · 2023-07-13

ApplicantVoco GmbH
Decision Date2023-07-13
Product CodeEBF
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Admira Fusion 5 is a medical device manufactured by Voco GmbH. It received FDA 510(k) clearance on 2023-07-13 under approval number K230877. The device is classified under product code EBF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Admira Fusion 5?

Admira Fusion 5 is a medical device that received FDA 510(k) clearance on 2023-07-13. It is manufactured by Voco GmbH. The 510(k) number is K230877.

When was Admira Fusion 5 approved by the FDA?

Admira Fusion 5 received FDA 510(k) clearance on 2023-07-13, under approval number K230877.

What company makes Admira Fusion 5?

Admira Fusion 5 is manufactured by Voco GmbH.

What is the FDA product code for Admira Fusion 5?

The FDA product code for Admira Fusion 5 is EBF.

Other Devices by Voco GmbH

View all 29 devices →

Related Devices (Code: EBF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.